TRANSDERMAL SYSTEMS (TDS) THAT CONTAIN INHIBITORS OF PHOSPHODIESTERASE IV

摘要

The invention relates to a transdermal system that is characterized by a content in a phosphodiesterase IV inhibitor, especially (-) rolipram or (R)-(-)-5-(4-methoxyphenyl-3-propoxy)-5-methyl-2-oxazolidinone.